These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 34085699)

  • 21. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma.
    Huang R; Chen Z; Li W; Fan C; Liu J
    Int J Oncol; 2020 May; 56(5):1199-1211. PubMed ID: 32319580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Prognostic Value, Immune Implication and Biological Function of
    Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
    Front Immunol; 2021; 12():723293. PubMed ID: 34899687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular Carcinoma.
    Chen J; Zhang L; Lu CH; Xu CZ
    Comb Chem High Throughput Screen; 2024; 27(14):2110-2124. PubMed ID: 38213141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
    Wang N; Zhou X; Tang F; Wang X; Zhu X
    Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Wu M; Jiang L
    Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
    Da BB; Luo S; Huang M; Song F; Ding R; Xiao Y; Fu Y; Yang YS; Wang HL
    Comput Math Methods Med; 2022; 2022():2415129. PubMed ID: 35035517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma.
    Su Q; Li L; Li X; Li W; Zhang X; Dong Y; Han L; Wang D; Ran J
    World J Surg Oncol; 2022 Dec; 20(1):382. PubMed ID: 36464675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma.
    Mei J; Yang X; Xia D; Zhou W; Gu D; Wang H; Liu C
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1384. PubMed ID: 32588988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
    Zou Y; Ruan S; Jin L; Chen Z; Han H; Zhang Y; Jian Z; Lin Y; Shi N; Jin H
    Med Sci Monit; 2020 Aug; 26():e925289. PubMed ID: 32863381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker.
    Chen R; Zhang Y
    J Cell Mol Med; 2020 Oct; 24(20):12107-12118. PubMed ID: 32935479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
    Li Y; He X; Zhang X; Xu Y; Wu Y; Xu X
    Life Sci; 2021 Jan; 265():118799. PubMed ID: 33220285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma.
    Subat S; Mogushi K; Yasen M; Kohda T; Ishikawa Y; Tanaka H
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):675-684. PubMed ID: 30564899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma.
    Ding J; Xu K; Zhang J; Lin B; Wang Y; Yin S; Xie H; Zhou L; Zheng S
    BMB Rep; 2018 Dec; 51(12):630-635. PubMed ID: 30293547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
    Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
    Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.
    Huang H; Lan C; Wei Y; Nong J; Liao X; Ye X; Deng G; Peng T; Zhou X
    Aging (Albany NY); 2024 Mar; 16(7):6229-6261. PubMed ID: 38552222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD74 facilitates immunotherapy response by shaping the tumor microenvironment of hepatocellular carcinoma.
    Cheng J; Li J; Jiang X; Ma X; Li B; Zhai H; Luo X; Zhou Y; Wu J; Zhang Z; Chen S; Wang Y
    Mol Med; 2024 Aug; 30(1):116. PubMed ID: 39118044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.